Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 106

1.

Effects of 6 months glucagon-like peptide-1 receptor agonist treatment on endothelial function in type 2 diabetes mellitus patients.

Hopkins ND, Cuthbertson DJ, Kemp GJ, Pugh C, Green DJ, Cable NT, Jones H.

Diabetes Obes Metab. 2013 Aug;15(8):770-3. doi: 10.1111/dom.12089. Epub 2013 Mar 27.

PMID:
23451821
[PubMed - indexed for MEDLINE]
2.

Effects of improved glycaemic control on endothelial function in patients with type 2 diabetes.

Bagg W, Whalley GA, Gamble G, Drury PL, Sharpe N, Braatvedt GD.

Intern Med J. 2001 Aug;31(6):322-8.

PMID:
11529585
[PubMed - indexed for MEDLINE]
3.

Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus.

Kelly AS, Thelen AM, Kaiser DR, Gonzalez-Campoy JM, Bank AJ.

Vasc Med. 2007 Nov;12(4):311-8.

PMID:
18048467
[PubMed - indexed for MEDLINE]
4.

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease.

Nyström T, Gutniak MK, Zhang Q, Zhang F, Holst JJ, Ahrén B, Sjöholm A.

Am J Physiol Endocrinol Metab. 2004 Dec;287(6):E1209-15. Epub 2004 Sep 7.

PMID:
15353407
[PubMed - indexed for MEDLINE]
Free Article
5.

Improved glycaemia correlates with liver fat reduction in obese, type 2 diabetes, patients given glucagon-like peptide-1 (GLP-1) receptor agonists.

Cuthbertson DJ, Irwin A, Gardner CJ, Daousi C, Purewal T, Furlong N, Goenka N, Thomas EL, Adams VL, Pushpakom SP, Pirmohamed M, Kemp GJ.

PLoS One. 2012;7(12):e50117. doi: 10.1371/journal.pone.0050117. Epub 2012 Dec 6.

PMID:
23236362
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Determinants of vascular function in patients with type 2 diabetes.

Naka KK, Papathanassiou K, Bechlioulis A, Kazakos N, Pappas K, Tigas S, Makriyiannis D, Tsatsoulis A, Michalis LK.

Cardiovasc Diabetol. 2012 Oct 12;11:127. doi: 10.1186/1475-2840-11-127.

PMID:
23062182
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Beyond glucose lowering: glucagon-like peptide-1 receptor agonists, body weight and the cardiovascular system.

Vergès B, Bonnard C, Renard E.

Diabetes Metab. 2011 Dec;37(6):477-88. doi: 10.1016/j.diabet.2011.07.001. Epub 2011 Aug 25. Review.

PMID:
21871831
[PubMed - indexed for MEDLINE]
Free Article
8.

Apolipoprotein B-48 as a determinant of endothelial function in obese subjects with type 2 diabetes mellitus: effect of fenofibrate treatment.

Chan DC, Wong AT, Yamashita S, Watts GF.

Atherosclerosis. 2012 Apr;221(2):484-9. doi: 10.1016/j.atherosclerosis.2012.01.029. Epub 2012 Jan 26.

PMID:
22341868
[PubMed - indexed for MEDLINE]
9.

Strict glycaemic control improves skin microcirculation in patients with type 2 diabetes: a report from the Diabetes mellitus And Diastolic Dysfunction (DADD) study.

Jarnert C, Kalani M, Rydén L, Böhm F.

Diab Vasc Dis Res. 2012 Oct;9(4):287-95. Epub 2012 Feb 29.

PMID:
22377484
[PubMed - indexed for MEDLINE]
Free Article
10.

Cardiovascular benefits of GLP-1-based herapies in patients with diabetes mellitus type 2: effects on endothelial and vascular dysfunction beyond glycemic control.

Forst T, Weber MM, Pfützner A.

Exp Diabetes Res. 2012;2012:635472. doi: 10.1155/2012/635472. Epub 2012 Apr 17. Review.

PMID:
22577369
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Extra-pancreatic effects of incretin-based therapies: potential benefit for cardiovascular-risk management in type 2 diabetes.

van Genugten RE, Möller-Goede DL, van Raalte DH, Diamant M.

Diabetes Obes Metab. 2013 Jul;15(7):593-606. doi: 10.1111/dom.12050. Epub 2013 Jan 21. Review.

PMID:
23216746
[PubMed - indexed for MEDLINE]
12.

Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study.

Pitocco D, Zaccardi F, Tarzia P, Milo M, Scavone G, Rizzo P, Pagliaccia F, Nerla R, Di Franco A, Manto A, Rocca B, Lanza GA, Crea F, Ghirlanda G.

Diabetes Obes Metab. 2013 May;15(5):427-31. doi: 10.1111/dom.12041. Epub 2012 Dec 5.

PMID:
23167274
[PubMed - indexed for MEDLINE]
13.

Extraglycemic effects of glp-1-based therapeutics: addressing metabolic and cardiovascular risks associated with type 2 diabetes.

Herzlinger S, Horton ES.

Diabetes Res Clin Pract. 2013 Apr;100(1):1-10. doi: 10.1016/j.diabres.2012.11.009. Epub 2013 Jan 14. Review.

PMID:
23332049
[PubMed - indexed for MEDLINE]
14.

Coenzyme Q(10) improves endothelial dysfunction of the brachial artery in Type II diabetes mellitus.

Watts GF, Playford DA, Croft KD, Ward NC, Mori TA, Burke V.

Diabetologia. 2002 Mar;45(3):420-6.

PMID:
11914748
[PubMed - indexed for MEDLINE]
15.

Effects of pioglitazone and metformin on vascular endothelial function in patients with type 2 diabetes treated with sulfonylureas.

Naka KK, Papathanassiou K, Bechlioulis A, Pappas K, Kazakos N, Kanioglou C, Kostoula A, Vezyraki P, Makriyiannis D, Tsatsoulis A, Michalis LK.

Diab Vasc Dis Res. 2012 Jan;9(1):52-8. doi: 10.1177/1479164111424515. Epub 2011 Nov 2.

PMID:
22049096
[PubMed - indexed for MEDLINE]
Free Article
16.

Improved endothelial function with metformin in type 2 diabetes mellitus.

Mather KJ, Verma S, Anderson TJ.

J Am Coll Cardiol. 2001 Apr;37(5):1344-50.

PMID:
11300445
[PubMed - indexed for MEDLINE]
Free Article
17.

Blood pressure-lowering effects of GLP-1 receptor agonists exenatide and liraglutide: a meta-analysis of clinical trials.

Wang B, Zhong J, Lin H, Zhao Z, Yan Z, He H, Ni Y, Liu D, Zhu Z.

Diabetes Obes Metab. 2013 Aug;15(8):737-49. doi: 10.1111/dom.12085. Epub 2013 Mar 20.

PMID:
23433305
[PubMed - indexed for MEDLINE]
18.

Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: results from an observational research.

Irace C, De Luca S, Shehaj E, Carallo C, Loprete A, Scavelli F, Gnasso A.

Diab Vasc Dis Res. 2013 Jan;10(1):72-7. doi: 10.1177/1479164112449562. Epub 2012 Jun 25.

PMID:
22732108
[PubMed - indexed for MEDLINE]
Free Article
19.

Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.

Wang JS, Lin SD, Lee WJ, Su SL, Lee IT, Tu ST, Tseng YH, Lin SY, Sheu WH.

Clin Ther. 2011 Dec;33(12):1932-42. doi: 10.1016/j.clinthera.2011.10.014. Epub 2011 Nov 10.

PMID:
22078152
[PubMed - indexed for MEDLINE]
20.

Effects of combined exenatide and pioglitazone therapy on hepatic fat content in type 2 diabetes.

Sathyanarayana P, Jogi M, Muthupillai R, Krishnamurthy R, Samson SL, Bajaj M.

Obesity (Silver Spring). 2011 Dec;19(12):2310-5. doi: 10.1038/oby.2011.152. Epub 2011 Jun 9.

PMID:
21660077
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk